عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

Wadi Al-Disah, a Captivating Illustration of Saudi Arabian Nature

A view of Wadi al-Disah in Saudi Arabia. (SPA)
A view of Wadi al-Disah in Saudi Arabia. (SPA)
TT
TT

Wadi Al-Disah, a Captivating Illustration of Saudi Arabian Nature

A view of Wadi al-Disah in Saudi Arabia. (SPA)
A view of Wadi al-Disah in Saudi Arabia. (SPA)

Winter has its splendor in Saudi Arabia, especially in the north, and even in parts of the country that are characterized by moderate weather in the summer, like the south. Many tourists and visitors flock to the country at this time of every year.

This year is no different as the Kingdom succeeded in curbing the spread of the Covid-19 pandemic.

“Winter is around you” is a Saudi marketing slogan that highlights the importance of this season for the tourism sector in Saudi Arabia. Winter becomes more than just a season when one can enjoy a road trip in the desert, mountains, coasts and valleys.

Wadi Al-Disah, one of the most visited locations in Saudi Arabia this year, is a valley that is located in the heart of the Prince Mohammed bin Salman Nature Reserve and extends into the city of Neom. Wadi Al-Disah boasts some of the most beautiful natural landscapes in the Kingdom, with its crystal-clear streams, flowing springs, lush patches of green and towering palm trees. The valley’s Nabataean facade and rock-carved tombs only add to its beauty.

Asharq Al-Awsat met several tourists who came to enjoy Saudi Arabia’s natural beauty from across the globe. Through the lens of their cameras, they documented what they saw and posted the pictures on their social media.

Nataliya, a photographer from Ukraine, said that it was the first time that she visited the valley and that she and her husband couldn’t be more impressed with what they had seen. She added: “This valley is definitely the most beautiful place we have visited in our trip.”

A Brazilian tourist said that she decided to visit Wadi Al-Disah after she saw photos of the valley on Instagram. “I loved it ... Wadi Al-Disah is one of the most beautiful places I have ever seen,” she said, adding that she was captivated by its mesmerizing nature and unique landscapes.

Saudi photographer Younis Al-Dohaiman also said that he first discovered the valley while scrolling through Instagram photos of travelers who had visited it during winter.

Tourists can visit Wadi Al-Disah in winter or summer. Temperatures in the area range from 12 degrees Celsius in winter to 31 degrees during the summer, while it rains for eight months a year on average.

The Saudi Public Investment Fund intends to invest in new development projects in Wadi Al-Disah that aim to preserve the environment and wildlife of the valley, while hoping to transform it into a major touristic attraction.

Most Viewed

 
 
Varieties

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”